A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab Era

Sun Yat-sen University

Status: Unknown

Conditions: Diffuse Large B Cell Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT04624971

B2020-235-01

Details and patient eligibility

About

The purpose of this study is to determine the predictive value of a model of Nomogram Prognostic Index (NPI) in patients with Diffuse Large B cell lymphoma.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• histologically confirmed diagnosis of CD20+ DLBCL

Exclusion criteria

• primary central nervous system lymphoma
• "double-hit" lymphoma